SANDS LAB Inc.

As of June 30, 2026, SANDS LAB Inc. carries a market capitalization of 66.26B, placing it among publicly traded companies globally. Its enterprise value stands at 36.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, SANDS LAB Inc. has 15.27M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 6.27, and the price-to-book ratio stands at 1.35.

As of June 30, 2026, SANDS LAB Inc. trades at an EV/EBITDA multiple of 89.50 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.44 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 36.38B versus a market cap of 66.26B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SANDS LAB Inc. maintains a current ratio of 9.33, meaning it holds 9.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.01, indicating conservative leverage, while an interest coverage ratio of 1,973.26 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, SANDS LAB Inc. posted a negative return on equity (ROE) of -3.67, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.43, reflecting losses generated across the asset base. The company generates approximately 247.12M in revenue per employee across its workforce of 42.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, SANDS LAB Inc. recorded 152.58M in income tax expense. The company reported a pretax loss of -1.64B and -1.89B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, SANDS LAB Inc.'s stock has declined approximately 32.11% over the past 52 weeks. The 50-day moving average sits at 5,593.50, while the 200-day moving average is 5,953.73.

Over the twelve months ended June 30, 2026, SANDS LAB Inc. generated 10.56B in revenue and converted that into -1.89B in net income, yielding earnings per share of -117.65. EBITDA reached 406.49M, while operating income came in at -794.98M.

As of June 30, 2026, SANDS LAB Inc. holds 30.10B in cash and equivalents against 3.58M in total debt, resulting in a net debt position of -4.11B. Total book value stands at 49.26B, with working capital of 30.69B providing operational flexibility.

SANDS LAB Inc. produced 1.08B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -462.56M in capital expenditures, free cash flow totaled 614.08M - equivalent to 40.21 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -7.53 and net profit margin of -17.84 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, SANDS LAB Inc. paid dividends of 149.96 per share. The dividend payout ratio of -134.07 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.93, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.47, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SANDS LAB Inc. shareholders.

As of June 30, 2026, SANDS LAB Inc. has an Altman Z-Score of 12.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.